D. Papamichael
- Hepatology top 1%
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies 12
- Cancer Treatment and Pharmacology 4
- Colorectal Cancer Surgical Treatments 3
-
- Genetic factors in colorectal cancer 5
-
- Gastric Cancer Management and Outcomes 5
- Lung Cancer Treatments and Mutations 4
- Dermatology top 5%
-
- Chronic Lymphocytic Leukemia Research 3
-
- Cancer Genomics and Diagnostics 3
D. Papamichael
26 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Hepatology 916
- Oncology 3.0k
- Pathology and Forensic Medicine 567
- Pulmonary and Respiratory Medicine 958
- Dermatology 171
Countries citing papers authored by D. Papamichael
This map shows the geographic impact of D. Papamichael's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Papamichael with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Papamichael more than expected).
Fields of papers citing papers by D. Papamichael
This network shows the impact of papers produced by D. Papamichael. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Papamichael. The network helps show where D. Papamichael may publish in the future.
Co-authorship network
The 25 scholars most cited alongside D. Papamichael, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 19 | |
| 2 | 2021 | 3 | |
| 3 | 2015 | 20 | |
| 4 | Barrett's esophagus: treatment or observation of a major precursor factor of esophageal cancer? | 2012 | 3 |
| 5 | 2010 | 33 | |
| 6 | 2008 | 134 | |
| 7 | 2008 | 4 | |
| 8 | 2003 | 33 | |
| 9 | 2003 | 14 | |
| 10 | 2001 | 26 | |
| 11 | Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancerbreakdown → | 2000 | 3040 |
| 12 | 2000 | 59 | |
| 13 | 1999 | 10 | |
| 14 | 1998 | 67 | |
| 15 | 1998 | 6 | |
| 16 | 1998 | 16 | |
| 17 | 1997 | 94 | |
| 18 | 1996 | 8 | |
| 19 | 1996 | 26 | |
| 20 | 1976 | 1 |
About D. Papamichael
D. Papamichael is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine, having authored 26 papers that have together received 3.7k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (12 papers), Genetic factors in colorectal cancer (5 papers), Gastric Cancer Management and Outcomes (5 papers), Cancer Treatment and Pharmacology (4 papers), Lung Cancer Treatments and Mutations (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Colorectal Cancer Surgical Treatments (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Hepatology (916 citations), Oncology (3.0k citations) and Pathology and Forensic Medicine (567 citations). D. Papamichael has collaborated with scholars based in United Kingdom, France and Greece. Frequent co-authors include Michel Seymour, Arié Figer, N Le Bail, M. Homerin, C. Wilson, Christophe Louvet, Filippo de Braud, H. Cortés-Funes, Aimery de Gramont and F. Morvan. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Stem Cells and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.